Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of KSR-001 (Rebamipide) in Dry Eye Syndrome
NCT05017844Phase 3Completed
- Sponsor
- Kukje Pharm
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide in dry eye syndrome (DED), sponsored by Kukje Pharm. Started Feb 2020; status: completed.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05017844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017844.